CDMO - Avid Bioservices, Inc. Stock Price and Quote

CDMO [NASD]

Index	-	P/E	14.13	EPS (ttm)	1.29	Insider Own	0.30%	Shs Outstand	62.39M	Perf Week	3.76%
Market Cap	1.14B	Forward P/E	195.59	EPS next Y	0.09	Insider Trans	-24.11%	Shs Float	61.26M	Perf Month	10.51%
Income	116.50M	PEG	0.94	EPS next Q	0.00	Inst Own	-	Short Float / Ratio	9.47% / 9.65	Perf Quarter	34.64%
Sales	140.70M	P/S	8.11	EPS this Y	-95.20%	Inst Trans	5.45%	Short Interest	5.80M	Perf Half Y	-5.60%
Book/sh	2.97	P/B	6.12	EPS next Y	615.38%	ROA	26.30%	Target Price	21.75	Perf Year	-17.88%
Cash/sh	0.95	P/C	19.06	EPS next 5Y	15.00%	ROE	64.70%	52W Range	11.30 - 22.20	Perf YTD	32.10%
Dividend	-	P/FCF	-	EPS past 5Y	86.70%	ROI	41.20%	52W High	-18.06%	Beta	1.80
Dividend %	-	Quick Ratio	1.00	Sales past 5Y	15.70%	Gross Margin	21.40%	52W Low	60.97%	ATR	0.93
Employees	321	Current Ratio	1.50	Sales Q/Q	20.60%	Oper. Margin	2.70%	RSI (14)	57.59	Volatility	3.92% 6.30%
Optionable	Yes	Debt/Eq	0.77	EPS Q/Q	-79.50%	Profit Margin	82.80%	Rel Volume	0.79	Prev Close	18.58
Shortable	Yes	LT Debt/Eq	0.77	Earnings	Mar 13 AMC	Payout	0.00%	Avg Volume	601.43K	Price	18.19
Recom	1.70	SMA20	7.22%	SMA50	9.41%	SMA200	10.31%	Volume	472,751	Change	-2.10%

Mar-14-23

Upgrade

KeyBanc Capital Markets

Sector Weight → Overweight

$20

Dec-08-21

Downgrade

KeyBanc Capital Markets

Overweight → Sector Weight

Mar-17-21

Initiated

RBC Capital Mkts

Outperform

$21

Nov-10-20

Initiated

KeyBanc Capital Markets

Overweight

$12

Dec-10-19

Upgrade

First Analysis Sec

Outperform → Strong Buy

Oct-17-19

Initiated

Stephens

Overweight

Oct-16-19

Initiated

Craig Hallum

Buy

$11

Jun-28-19

Upgrade

Janney

Neutral → Buy

$10

May-09-19

Downgrade

Janney

Buy → Neutral

Mar-14-23 12:35PM	Why Avid Bioservices Stock Is Surging Today Motley Fool +35.96%
11:20AM	Avid Bioservices, Inc. (NASDAQ:CDMO) Q3 2023 Earnings Call Transcript Insider Monkey
07:22AM	Declining Stock and Solid Fundamentals: Is The Market Wrong About Avid Bioservices, Inc. (NASDAQ:CDMO)? Simply Wall St.
06:07AM	Q3 2023 Avid Bioservices Inc Earnings Call Thomson Reuters StreetEvents
Mar-13-23 05:55PM	Avid Bioservices (CDMO) Q3 Earnings and Revenues Top Estimates Zacks
04:05PM	Loading…
04:05PM	Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent Developments GlobeNewswire
Mar-10-23 07:24AM	Steer Clear Of These 4 Toxic Stocks to Avoid Losses Zacks -5.87%
Mar-06-23 04:05PM	Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2023 After Market Close on March 13, 2023 GlobeNewswire -5.49%
Feb-23-23 10:50AM	13 High Growth Pharma Stocks that are Profitable Insider Monkey
Feb-16-23 08:43AM	Is Avid Bioservices (CDMO) a Good Investment Opportunity? Insider Monkey
Feb-14-23 04:33PM	11 Most Undervalued Biotech Stocks To Buy According To Hedge Funds Insider Monkey
Dec-09-22 01:39PM	Avid Bioservices, Inc. (NASDAQ:CDMO) Q2 2023 Earnings Call Transcript Insider Monkey
07:33AM	Avid Bioservices Second Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags Simply Wall St.
Dec-06-22 05:35PM	Avid Bioservices (CDMO) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:30PM	Edited Transcript of CDMO.OQ earnings conference call or presentation 6-Dec-22 9:30pm GMT Thomson Reuters StreetEvents
04:05PM	Loading…
04:05PM	Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2022 and Recent Developments GlobeNewswire
Nov-29-22 04:05PM	Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022 GlobeNewswire
Nov-17-22 06:03AM	Avid Bioservices (NASDAQ:CDMO) jumps 12% this week, though earnings growth is still tracking behind five-year shareholder returns Simply Wall St.
Nov-16-22 08:05AM	Avid Bioservices Appoints Oksana Lukash as Vice President, People GlobeNewswire -6.59%
Nov-02-22 04:05PM	Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference GlobeNewswire
Oct-17-22 09:55AM	Does Avid Bioservices (CDMO) Have the Potential to Rally 61% as Wall Street Analysts Expect? Zacks
Oct-10-22 08:30AM	TOMI to Install Custom Engineered Integrated iHP System in Avid Bioservices, Inc. Viral Vector Manufacturing Facility in California GlobeNewswire
Oct-05-22 06:47AM	Are Strong Financial Prospects The Force That Is Driving The Momentum In Avid Bioservices, Inc.'s NASDAQ:CDMO) Stock? Simply Wall St.
Sep-27-22 04:05PM	Avid Bioservices to Participate in RBC Global CDMO Conference GlobeNewswire
Sep-22-22 08:05AM	Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations GlobeNewswire
Sep-08-22 06:31AM	We Ran A Stock Scan For Earnings Growth And Avid Bioservices (NASDAQ:CDMO) Passed With Ease Simply Wall St. +6.03%
Sep-07-22 04:05PM	Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference GlobeNewswire
Sep-06-22 11:00PM	Avid Bioservices, Inc. (CDMO) Q1 2023 Earnings Call Transcript Motley Fool
05:25PM	Avid Bioservices (CDMO) Beats Q1 Earnings and Revenue Estimates Zacks
04:30PM	Edited Transcript of CDMO.OQ earnings conference call or presentation 6-Sep-22 8:30pm GMT Thomson Reuters StreetEvents
04:05PM	Loading…
04:05PM	Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments GlobeNewswire
Sep-01-22 08:05AM	Avid Bioservices Appoints Pramthesh (Prem) Patel, Ph.D., as Vice President, Process Development for Mammalian Cell Business GlobeNewswire
Aug-30-22 04:05PM	Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2023 After Market Close on September 6, 2022 GlobeNewswire
Aug-18-22 12:42PM	Is Avid Bioservices (CDMO) a Worthy Investment Pick? Insider Monkey
Aug-02-22 09:11PM	Is Avid Bioservices (CDMO) a Great Buy? Insider Monkey
Jun-30-22 07:31AM	Read How Avid Bioservices Fared In Q4 Benzinga
03:00AM	Avid Bioservices, Inc. (CDMO) Q4 2022 Earnings Call Transcript Motley Fool
Jun-29-22 04:05PM	Avid Bioservices Reports Financial Results for Fourth Quarter and Full Fiscal Year Ended April 30, 2022 and Recent Developments GlobeNewswire
Jun-22-22 04:05PM	Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2022 After Market Close on June 29, 2022 GlobeNewswire
Jun-16-22 08:00AM	Avid Bioservices, Inc. and CRB highlight efforts that enabled opening of first phase of new viral vector facility in California in only eight months PR Newswire
Jun-14-22 08:05AM	Avid Bioservices Announces Launch of Analytical and Process Development Suites Within New, World-Class Viral Vector Development and Manufacturing Facility GlobeNewswire
Jun-13-22 08:05AM	Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business GlobeNewswire
May-16-22 12:43PM	Those who invested in Avid Bioservices (NASDAQ:CDMO) three years ago are up 258% Simply Wall St. -5.35%
May-11-22 08:13AM	7 Micro-Cap Stocks to Buy and Hold for the Next 10 Years InvestorPlace
Apr-05-22 01:21PM	Is Avid Bioservices, Inc. (NASDAQ:CDMO) A High Quality Stock To Own? Simply Wall St. -8.69%
Mar-16-22 04:05PM	Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Forum GlobeNewswire
Mar-08-22 11:00PM	Avid Bioservices, Inc. (CDMO) Q3 2022 Earnings Call Transcript Motley Fool
05:35PM	Avid Bioservices (CDMO) Q3 Earnings and Revenues Top Estimates Zacks
04:09PM	Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2022 and Recent Developments GlobeNewswire
Mar-01-22 04:05PM	Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2022 after Market Close on March 8, 2022 GlobeNewswire
Feb-27-22 10:56PM	Is Avid Bioservices (CDMO) A Smart Long-Term Buy? Insider Monkey
Feb-25-22 06:15PM	Avid Bioservices (CDMO) Stock Sinks As Market Gains: What You Should Know Zacks
Feb-23-22 06:45PM	Arcus Biosciences, Inc. (RCUS) Q4 Earnings and Revenues Surpass Estimates Zacks
Feb-21-22 11:26AM	Avid (CDMO) to Report Q3 Earnings: What's in the Cards? Zacks
Feb-16-22 06:15PM	Avid Bioservices (CDMO) Stock Sinks As Market Gains: What You Should Know Zacks
Feb-10-22 06:15PM	Avid Bioservices (CDMO) Stock Moves -1.6%: What You Should Know Zacks
Feb-04-22 05:11AM	Here's Why Avid Bioservices (NASDAQ:CDMO) Can Manage Its Debt Responsibly Simply Wall St.
Feb-03-22 09:38AM	Redwood Investments, LLC Buys Asbury Automotive Group Inc, Avid Bioservices Inc, SiTime Corp, ... GuruFocus.com
Feb-01-22 06:15PM	Avid Bioservices (CDMO) Gains But Lags Market: What You Should Know Zacks
Jan-21-22 06:15PM	Avid Bioservices (CDMO) Stock Moves -1.67%: What You Should Know Zacks
Jan-14-22 11:22AM	Avid Bioservices, Inc. (CDMO) Fell Out Of Favor With Hedge Funds? Insider Monkey
Jan-10-22 08:05AM	Avid Bioservices Announces Official Opening of Second Downstream Processing Suite Within Myford North Facility GlobeNewswire
Jan-07-22 01:38PM	Future Financial Wealth Managment LLC Buys The Energy Select Sector SPDR Fund, Global X U.S. ... GuruFocus.com
Dec-30-21 04:51AM	Zacks Investment Ideas feature highlights: Gilead Sciences, Regeneron and Avid Bioservices Zacks
Dec-29-21 02:16PM	Follow The Leader: 3 Biopharma Stocks Displaying Relative Strength Zacks
Dec-21-21 06:41AM	Avid Bioservices (CDMO) Sees Hammer Chart Pattern: Time to Buy? Zacks
Dec-15-21 10:00AM	Avid Bioservices (CDMO) Loses 24.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks
Dec-09-21 11:55AM	10 Stocks Making Headlines After Financial Results Insider Monkey
Dec-08-21 03:14AM	Avid Bioservices (CDMO) Tops Q2 Earnings and Revenue Estimates Zacks
Dec-07-21 11:30PM	Avid Bioservices, inc (CDMO) Q2 2022 Earnings Call Transcript Motley Fool
04:05PM	Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2021 and Recent Developments GlobeNewswire
Dec-06-21 11:32AM	15 Best Stocks to Buy for 2022 According to Analysts Insider Monkey
04:39AM	While shareholders of Avid Bioservices (NASDAQ:CDMO) are in the black over 5 years, those who bought a week ago aren't so fortunate Simply Wall St.
Dec-03-21 11:58AM	7 A-Rated Biotechs to Buy for the Long Run InvestorPlace -8.22%
Dec-02-21 07:26PM	The Cooper Companies (COO) Q4 Earnings Lag Estimates Zacks
Nov-30-21 04:05PM	Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2022 After Market Close on December 7, 2021 GlobeNewswire
Nov-24-21 03:00PM	Avid Bioservices (CDMO) Earnings Expected to Grow: What to Know Ahead of Q2 Release Zacks
Nov-04-21 08:05AM	Avid Bioservices Appoints Elie G. Hanania, Ph.D., as Vice President, Process Development, Viral Vector Technologies GlobeNewswire
Oct-26-21 06:39PM	Why Avid Bioservices Stock Surged 14% Today Motley Fool +14.00%
08:05AM	Avid Bioservices to Join S&P SmallCap 600 Index GlobeNewswire
Oct-25-21 06:58PM	Avid Bioservices Set to Join S&P SmallCap 600 PR Newswire
05:13PM	Here is What Hedge Funds Think About Avid Bioservices, Inc. (CDMO) Insider Monkey
Oct-14-21 08:05AM	Avid Bioservices Announces Expansion into Viral Vector Development and Manufacturing Services for Cell and Gene Therapy GlobeNewswire +5.98%
Oct-07-21 08:05AM	Avid Bioservices Appoints Matthew Kwietniak as Chief Commercial Officer GlobeNewswire
06:44AM	Is Avid Bioservices, Inc.'s (NASDAQ:CDMO) 29% ROE Better Than Average? Simply Wall St.
Oct-01-21 09:33AM	Reata (RETA) Confirms Omaveloxolone NDA Filing in Q1 2022 Zacks
Sep-14-21 10:00AM	Down 20.1% in 4 Weeks, Here's Why Avid Bioservices (CDMO) Looks Ripe for a Turnaround Zacks
Sep-09-21 03:00PM	Avid Bioservices, inc (CDMO) Q1 2021 Earnings Call Transcript Motley Fool -12.05%
Sep-08-21 04:05PM	Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2021 and Recent Developments GlobeNewswire
Sep-02-21 04:05PM	Avid Bioservices to Participate at Upcoming Investor Conferences GlobeNewswire
Sep-01-21 04:05PM	Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2022 After Market Close on September 8, 2021 GlobeNewswire
Aug-08-21 03:59AM	We Think Avid Bioservices (NASDAQ:CDMO) Can Manage Its Debt With Ease Simply Wall St.
Jul-29-21 12:19PM	Is Avid Bioservices (CDMO) A Great Long-Term Investment? Insider Monkey
Jul-20-21 09:27AM	Hedge Funds Arent Crazy About Avid Bioservices, Inc. (CDMO) Anymore Insider Monkey
Jul-01-21 08:05AM	Avid Bioservices Announces Appointment of Esther M. Alegria, Ph.D., to Board of Directors GlobeNewswire
Jun-29-21 07:00PM	Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript Motley Fool
04:05PM	Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent Developments GlobeNewswire
Jun-24-21 02:05AM	Breakeven On The Horizon For Avid Bioservices, Inc. (NASDAQ:CDMO) Simply Wall St.
Jun-22-21 04:05PM	Avid Bioservices to Report Financial Results For Quarter and Fiscal Year Ended April 30, 2021 After Market Close on June 29, 2021 GlobeNewswire
03:00PM	Avid Bioservices (CDMO) Q4 Earnings Preview: What's in the Cards? Zacks

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hart Daniel R	Chief Financial Officer	Mar 14	Option Exercise	5.66	2,000	11,320	48,957	Mar 16 07:59 PM
Hart Daniel R	Chief Financial Officer	Mar 14	Sale	19.00	5,000	95,000	46,957	Mar 16 07:59 PM
Hancock Richard B	Director	Mar 01	Option Exercise	4.67	5,000	23,350	44,134	Mar 03 07:43 PM
Hancock Richard B	Director	Mar 01	Sale	16.59	5,000	82,971	39,134	Mar 03 07:43 PM
Hancock Richard B	Director	Feb 01	Option Exercise	4.67	5,000	23,350	44,134	Feb 03 07:39 PM
Hancock Richard B	Director	Feb 01	Sale	16.02	5,000	80,077	39,134	Feb 03 07:39 PM
Alegria Esther M.	Director	Jan 13	Sale	16.32	5,321	86,856	0	Jan 17 07:41 PM
Hancock Richard B	Director	Jan 12	Option Exercise	4.58	2,621	12,011	40,769	Jan 13 08:03 PM
Hancock Richard B	Director	Jan 12	Sale	16.00	5,000	80,000	39,134	Jan 13 08:03 PM
Green Nicholas Stewart	President & CEO	Jan 10	Sale	14.44	8,100	116,977	83,729	Jan 11 07:38 PM
Hart Daniel R	Chief Financial Officer	Jan 10	Sale	14.44	1,499	21,647	49,957	Jan 11 07:45 PM
Ziebell Mark R	V. P., General Counsel	Jan 10	Sale	14.44	1,150	16,607	38,897	Jan 11 07:46 PM
Hancock Richard B	Director	Dec 02	Option Exercise	4.53	10,000	45,300	46,881	Dec 06 07:40 PM
Hancock Richard B	Director	Dec 02	Sale	16.11	10,000	161,122	36,881	Dec 06 07:40 PM
Green Nicholas Stewart	President & CEO	Oct 10	Sale	17.90	7,493	134,121	76,615	Oct 11 08:27 PM
Hart Daniel R	Chief Financial Officer	Oct 10	Sale	17.90	1,262	22,590	47,020	Oct 11 08:27 PM
Hancock Richard B	Director	Oct 03	Option Exercise	4.57	5,000	22,841	40,516	Oct 05 07:56 PM
Hancock Richard B	Director	Oct 03	Sale	18.43	5,000	92,134	36,881	Oct 05 07:56 PM
Hancock Richard B	Director	Sep 01	Option Exercise	4.53	2,987	13,531	40,202	Sep 02 07:50 PM
Hancock Richard B	Director	Sep 01	Sale	17.12	3,321	56,844	36,881	Sep 02 07:50 PM
Green Nicholas Stewart	President & CEO	Aug 01	Sale	19.22	19,058	366,278	69,708	Aug 02 08:14 PM
Hancock Richard B	Director	Aug 01	Sale	19.40	5,000	96,979	37,215	Aug 02 08:15 PM
Hart Daniel R	Chief Financial Officer	Jul 11	Sale	17.75	4,324	76,768	44,661	Jul 12 08:34 PM
Green Nicholas Stewart	President & CEO	Jul 11	Sale	17.75	2,939	52,176	51,266	Jul 12 08:33 PM
Green Nicholas Stewart	President & CEO	Jul 08	Sale	17.53	22,725	398,412	48,632	Jul 11 07:41 PM
Hart Daniel R	Chief Financial Officer	Jul 08	Sale	17.53	4,150	72,758	36,743	Jul 11 07:42 PM
Hancock Richard B	Director	Jul 05	Option Exercise	4.53	5,000	22,650	40,201	Jul 06 08:01 PM
Hancock Richard B	Director	Jul 05	Sale	16.03	5,000	80,157	35,201	Jul 06 08:01 PM
Hancock Richard B	Director	Jun 27	Option Exercise	4.67	3,802	17,755	42,738	Jun 28 07:38 PM
Hancock Richard B	Director	Jun 27	Sale	16.07	7,537	121,086	35,201	Jun 28 07:38 PM
Hancock Richard B	Director	Jun 24	Option Exercise	4.67	1,211	5,654	41,386	Jun 28 07:38 PM
Hancock Richard B	Director	Jun 24	Sale	16.02	2,463	39,454	38,936	Jun 28 07:38 PM
Ziebell Mark R	V. P., General Counsel	Jun 17	Option Exercise	3.29	6,428	21,148	14,531	Jun 21 07:33 PM
Green Nicholas Stewart	President & CEO	Apr 11	Sale	18.56	2,939	54,554	28,103	Apr 12 07:50 PM
Hart Daniel R	Chief Financial Officer	Apr 11	Sale	18.56	726	13,476	28,770	Apr 12 07:54 PM
Ziebell Mark R	V. P., General Counsel	Apr 11	Sale	18.56	368	6,831	8,103	Apr 12 07:58 PM
Hancock Richard B	Director	Apr 01	Option Exercise	4.67	5,000	23,350	40,200	Apr 05 07:43 PM
Hancock Richard B	Director	Apr 01	Sale	21.21	5,000	106,064	35,200	Apr 05 07:43 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience